Moran Wealth Management’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.74M Sell
63,905
-4,987
-7% -$214K 0.08% 272
2025
Q4
$3.02M Sell
68,892
-2,925
-4% -$121K 0.09% 253
2025
Q3
$2.97M Sell
71,817
-23,495
-25% -$944K 0.09% 247
2025
Q2
$4.2M Buy
95,312
+2,040
+2% +$81.5K 0.13% 207
2025
Q1
$3.44M Buy
93,272
+65,186
+232% +$2.32M 0.12% 226
2024
Q4
$935K Sell
28,086
-1,860
-6% -$60.3K 0.03% 301
2024
Q3
$777K Buy
29,946
+11,119
+59% +$276K 0.02% 322
2024
Q2
$423K Buy
18,827
+6,969
+59% +$155K 0.01% 352
2024
Q1
$281K Buy
+11,858
New +$264K 0.01% 389

Other funds holding EXEL

Moran Wealth Management's EXEL Position: Q1 2026 in Review

Moran Wealth Management reduced its Exelixis (EXEL) stake by 7.2% in Q1 2026, selling an estimated $214K and leaving 63,905 shares worth $2.74M. The position accounts for 0.08% of the portfolio, ranked #272.

Moran Wealth Management first reported a position in EXEL in Q1 2024 and has held it in 9 quarters since. The position peaked at $4.2M in Q2 2025. 694 funds tracked by Wall St. Rank hold EXEL as of Q1 2026.

  • Moran Wealth Management held 63,905 shares of Exelixis worth $2.74M as of Q1 2026.
  • Moran Wealth Management sold 4,987 Exelixis shares in Q1 2026, an estimated $214K.
  • Exelixis made up 0.08% of Moran Wealth Management's portfolio in Q1 2026, its #272 holding.
  • Moran Wealth Management first reported a position in Exelixis in Q1 2024 and has held it in 9 quarters since.
  • Moran Wealth Management's Exelixis position peaked at $4.2M in Q2 2025.
  • 694 funds tracked by Wall St. Rank held Exelixis as of Q1 2026.

Based on Moran Wealth Management's 13F filing for Q1 2026, filed 27 Apr 2026.